Latest News & Features
Americas
Artificial intelligence is being used increasingly in the pharma and biotech industries, and questions are being asked about the legal status of innovations created by the technology, as MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch reports. 31 May 2018
Asia
In India, there are two core areas of the antibody patenting field that are unsettled and need correcting, as Archana Shanker and Nupur Maithani of Anand and Anand explain. 31 May 2018
Asia-Pacific
A court has rejected an appeal by the Australian Competition and Consumer Commission, in a decision which confirmed that deals made by Pfizer in relation to generic cholesterol-lowering medication do not constitute a misuse of its market power. 31 May 2018
Americas
Takeda and Aurobindo have agreed to dismiss a dispute over Aurobindo’s filing of an Abbreviated New Drug Application (ANDA) for a generic version of Prevacid Solutab (lansoprazole). 31 May 2018
Asia-Pacific
UK-based Crescendo Biologics has agreed a global licensing deal with biopharma company Zai Lab which will see Zai Lab develop and commercialise an antibody, “VH domain therapeutic”, for applications in inflammatory diseases. 31 May 2018
Americas
The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto. 30 May 2018
Americas
Research and development, strong IP rights and good international relations are all factors in Brazil’s rise as a soybean-producing powerhouse, as Gabriel Di Blasi and Matheus Gil do Amaral of Di Blasi Parente & Associados report. 29 May 2018
Americas
Molecular diagnostics company Myriad Genetics has agreed to acquire Counsyl, a genetic screening company, for $375 million. 29 May 2018
Americas
Pfizer has sued Canadian pharmaceutical company Apotex over its plan to make and sell a generic version of Pfizer’s Inlyta tablets. 29 May 2018
Big Pharma
The European Commission has proposed a change in IP rules to allow pharmaceutical companies to produce generic drugs for export to non-EU countries that don’t have patent protection. 29 May 2018